Girls on Sexual Communication (Girls)

Effectiveness of the Girls Mobile Application on Sexual Communication Among Adolescent Girls

Adolescents' sexual health has been an important issue for health care professionals, education and society. The purpose of this study was to examine the impact of a mobile application on adolescent girls' sexual communication self-efficacy and sexual health outcomes. A total of 245 adolescent girls were recruited through purposive sampling between November 2020 and July 2021, with 133 in the experimental group and 112 in the control group. Data were collected at three time points: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2).

Study Overview

Detailed Description

Adolescents' sexual health has been an important issue for healthcare professionals, educators, and society. Conversations about sexual health are often sensitive and uncomfortable for young people. This is especially true for adolescent girls, who often struggle to assert their sexual desires or preferences in relationships. Empowering young women with communication and negotiation skills during sexual encounters is therefore crucial. To address this, we developed a sexual communication program based on the ADDIE instructional design model. The purpose of this study was to examine the impact of a mobile application on adolescent girls' sexual communication self-efficacy and sexual health outcomes. A total of 245 emerging adult women were recruited through purposive sampling between November 2020 and July 2021, with 133 in the experimental group and 112 in the control group. The experimental group received the sexual communication program, while the control group received routine care. Data were collected at three time points: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2).

Study Type

Interventional

Enrollment (Actual)

245

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taiwan
      • Kaohsiung, Taiwan, Taiwan, 807378
        • Kaohsiung Medical University Chung-Ho Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adolescent girls who use smartphones and mobile internet and have a habit of using LINE
  • Adolescent girls aged 15-24 [based on the United Nations definition of youth.

Exclusion Criteria

∙ individuals who are homosexual or have an uncertain sexual orientation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
routine care
Experimental: experimental group
mobile application
mobile application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sexual communication self-efficacy
Time Frame: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2)
The "Sexual Communication Self-Efficacy Scale" developed by Quinn-Nilas et al. (2016), including five factors: contraception communication, positive sexual messages, negative sexual messages, sexual history, and condom negotiation. The scale has 22 items, with scores ranging from 1 to 4. The higher the score, the more confident the respondent in communicating sexual issues with their partner.
baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 16, 2020

Primary Completion (Actual)

May 24, 2021

Study Completion (Actual)

May 24, 2021

Study Registration Dates

First Submitted

August 3, 2026

First Submitted That Met QC Criteria

August 31, 2026

First Posted (Actual)

September 2, 2026

Study Record Updates

Last Update Posted (Actual)

September 2, 2026

Last Update Submitted That Met QC Criteria

August 31, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NCKU HREC-F-108-370-2
  • MOST 108-2511-H-037-016-MY2 (Other Identifier: Ministry of science and technology)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe